Targeting of Adenovirus to Endothelial Cells by a Bispecific Single-Chain Diabody Directed against the Adenovirus Fiber Knob Domain and Human Endoglin (CD105)
Open Access
- 1 June 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (6) , 882-891
- https://doi.org/10.1006/mthe.2001.0342
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Targetable, Injectable Adenoviral Vector for Selective Gene Delivery to Pulmonary Endothelium in VivoMolecular Therapy, 2000
- Targeting of adenoviral vectors through a bispecific single-chain antibodyCancer Gene Therapy, 2000
- Genetic Targeting of Adenoviral VectorsMolecular Therapy, 2000
- Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglinEuropean Journal Of Cancer, 2000
- Fibroblast Growth Factor 2-Retargeted Adenoviral Vectors Exhibit a Modified Biolocalization Pattern and Display Reduced Toxicity Relative to Native Adenoviral VectorsHuman Gene Therapy, 2000
- Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using125I-labeled anti-endoglin monoclonal antibodiesInternational Journal of Cancer, 1999
- Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionFEBS Letters, 1999
- Toward Selection of Internalizing Antibodies from Phage LibrariesBiochemical and Biophysical Research Communications, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992